 Nabriva Therapeutics plc NASDAQ:NBRV Q2 2022 Results Conference Call August 3, 2022 4:30 PM ET Company Participants Dan Dolan - CFO Ted Schroeder - CEO Conference Call Participants Carl Byrnes - Northland Capital Markets Thomas Yip - HCW Operator Good morning, and welcome to the Nabriva Therapeutics Second Quarter 2022 Financial Results Conference Call. Operator Instructions Please note that this event is being recorded today. 